Rheumnow

Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: EULAR vs ACR vs GRAPPA Guidelines Alexis Ogdie, MD Choosing Systemic Therapies for Psoriatic Disease April Armstrong, MD Gender Differences in PsA Outcomes & Management Lihi Eder, MD

Dr. Jack Cush reviews the news and Journal reports from this past week on RheumNow.com -  including problems w/ falls, pain and treatment of Dupuytrens contractures.

Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: Lessons from Cardio-Rheumatology Clinic RA Brittany Weber, MD Nutrition in RA Monica Guma, MD Prevention of RA Hani El Gabalawy, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, including on where you should sit in clinic and why you should worry about secondary Sjogrens in RA.

Dr. Jack Cush reviews the news and journal reports from the past week - including a few contrary reports on infection, seropositivity and plasmapheresis.

Dr. Jack Cush has advise for Cesar and the superstitious and covers pregnancy, platelets, dialysis and vaccinations in Lupus.

Dr. Jack Cush reviews the news, journal reports and regulatory approvals from the past week.

Hear Dr. Richard Furie and Dr. Leanna Wise discuss clinical considerations related to the 2023 EULAR treatment recommendations for SLE. US-85292 last updated 2/24.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Are these associations with infection, biomarkers and weather real or imaginary? Linked or luck? Causal or casual?  You decide....

Dr. Jack Cush reviews the news and journal reports from the past 2 weeks on RheumNow.com; but begins with a discussion of what constitutes "immunosuppression" and how it applies to our patients.

Dr. Jack Cush answers audience clinical case questions sent by email or "ask Cush anything". Cases and questions from: Dr. William Hong - RA management in the setting of active TB or latent TB (LTBI) Dr. Vrishali Dalvi - relapsing polychondritis monitoring Dr. Ken Stark - ICI induced RA; management and breast cancer considerations Dr. Nada Skaf - Sarcoidosis in the maxilla Dr. Cush - acute onset (knee) monarthritis

Dr. Jack Cush reviews the journal reports from the past week on RheumNow.com. Highlights are summarized by three songs: "Stairway to Heaven", "Youre No Good", and "How Long (has this been going on)".

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week we discuss hipsters undergoing hip replacement, pregnancy outcomes in RA and the future of academic clinicians.

Tune in to Dr. Spiera and Dr. Lebovics to learn about ear, nose, and throat manifestations in granulomatosis with polyangiitis (GPA) and gain insights into daily life of a person living with severe active GPA. USA-569-80515.

Dr. Jack Cush reviews the terms in rheumatology that should no longer be used in the field of rheumatology. This lecture is part of the RheumNow Live 2024 meeting, being held January 27-28, 2024 in Dallas, TX (and virtually).

QD264 - To Aspirate or Not https://youtu.be/ek25MJ0dI7g?si=SKLnw92gkJeFw0BM QD265 - Suspend MTX How Long  https://youtu.be/N6-m-IDrnFc QD266 - GCA & Steroid Weaning https://youtu.be/Vyzd5_lMi_k QD267 - RA, SSZ, & MI https://youtu.be/p9uzqk6VO1s QD268 - ISR Management https://youtu.be/tztFzdA_oog

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. How good (or not) are rheumatologists and what to do about MTX nodulosis?

Dr. Jack Cush reviews highlights, advances and hot topics in rheumatology from 2023 and the RheumNow website.   2023 was a year of growth and new horizons while returning to operational and practice standards (in care and education) established before the pandemic.   Below is my top 10 list (in no particular order) of 2023 advances, game-changers, and developments that changed or will soon change rheumatologic practices.